Wesper
A state-of-the-art diagnostic and outcome management patch, that provides high-quality sleep analysis in maximal comfort.
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor investor investor | €0.0 | round |
| investor investor | €0.0 | round | |
| investor investor | €0.0 | round | |
| investor investor investor investor | €0.0 | round | |
| investor investor investor investor | €0.0 | round | |
| N/A | €0.0 | round | |
* | $7.5m | Series A | |
| Total Funding | 000k | ||
| USD | 2022 | 2023 |
|---|---|---|
| Revenues | 0000 | 0000 |
| % growth | - | 6 % |
| EBITDA | 0000 | 0000 |
| Profit | 0000 | 0000 |
| EV | 0000 | 0000 |
| EV / revenue | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 |
Source: Dealroom estimates
Related Content
Wesper operates in the healthcare technology sector, focusing on sleep diagnostics and improvement. The company provides a comprehensive, longitudinal sleep testing platform designed to deliver personalized data to both healthcare professionals and individuals. This data aims to improve adherence to sleep treatments and enhance clinical outcomes, ultimately helping users achieve better sleep quality. Wesper's primary clients include individuals suffering from sleep disorders such as sleep apnea, as well as healthcare providers seeking accurate and inclusive sleep data for informed decision-making.
The business model revolves around selling its sleep testing platform and related services. Revenue is generated through the sale of sleep testing kits, subscription-based access to the platform's data analytics, and partnerships with healthcare institutions. Wesper leverages advanced technology to offer reliable at-home healthcare solutions, making sleep diagnostics more accessible and effective.
Keywords: sleep diagnostics, healthcare technology, sleep apnea, personalized data, clinical outcomes, adherence improvement, at-home healthcare, sleep testing kits, data analytics, healthcare providers.